THE NICKLES GROUP, LLC for AMGEN
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Health Issues HCR
Monitored S. 3799, PREVENT Pandemics Act. Monitored issues related to FDA user fee agreements. Issues regarding timely access to medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
H.R. 5376, The Build Better Back Act and issue regarding drug pricing. Issues regarding ESRD payments. H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Monitored the FDA user fee agreements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.